Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $111.44
-
Support level$96.94
-
Resistance levelN/A
-
Beta0.3
-
RSI (14-day)51.2
- With a 48.4 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$63.15 | $117.41 | 91.6% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$85.74 | $101.63 | $112.32 | $115.00 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.0%
-
In the next month14.4%
-
In the next year45.2%
Period | Value |
---|---|
Historical (5 year) | 26.3% |
Last month | 35.5% |
Current estimate | 25.8% |
Next month forecast | 25.5% |